Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Anika Therapeutics (ANIK) Tax Rate (2016 - 2026)

Anika Therapeutics has reported Tax Rate over the past 17 years, most recently at 4.87% for Q1 2026.

  • Quarterly Tax Rate fell 229.0% to 4.87% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 6891.67% through Mar 2026, down 678973.0% year-over-year, with the annual reading at 71.49% for FY2025, 22019.0% up from the prior year.
  • Tax Rate was 4.87% for Q1 2026 at Anika Therapeutics, up from 9.34% in the prior quarter.
  • Over five years, Tax Rate peaked at 676.92% in Q3 2024 and troughed at 198.04% in Q4 2024.
  • The 5-year median for Tax Rate is 7.1% (2023), against an average of 27.26%.
  • Year-over-year, Tax Rate surged 66982bps in 2024 and then crashed -71892bps in 2025.
  • A 5-year view of Tax Rate shows it stood at 52.08% in 2022, then crashed by -38bps to 32.35% in 2023, then crashed by -712bps to 198.04% in 2024, then skyrocketed by 95bps to 9.34% in 2025, then skyrocketed by 48bps to 4.87% in 2026.
  • Per Business Quant, the three most recent readings for ANIK's Tax Rate are 4.87% (Q1 2026), 9.34% (Q4 2025), and 41.99% (Q3 2025).